K. Kondo, William Kim, M. Lechpammer, W. Kaelin (2003)
Inhibition of HIF2α Is Sufficient to Suppress pVHL-Defective Tumor GrowthPLoS Biology, 1
Cheng-Jun Hu, Liyi Wang, Lewis Chodosh, B. Keith, M. Simon (2003)
Differential Roles of Hypoxia-Inducible Factor 1α (HIF-1α) and HIF-2α in Hypoxic Gene RegulationMolecular and Cellular Biology, 23
M. Baba, S. Hirai, H. Yamada‐Okabe, K. Hamada, H. Tabuchi, Kazuki Kobayashi, K. Kondo, Minoru Yoshida, A. Yamashita, T. Kishida, N. Nakaigawa, Y. Nagashima, Y. Kubota, M. Yao, S. Ohno (2003)
Loss of von Hippel-Lindau protein causes cell density dependent deregulation of CyclinD1 expression through Hypoxia-inducible factorOncogene, 22
Catherine Thrash-Bingham, K. Tartof (1999)
aHIF: a natural antisense transcript overexpressed in human renal cancer and during hypoxia.Journal of the National Cancer Institute, 91 2
C. Warnecke, Z. Zaborowska, J. Kurreck, V. Erdmann, U. Frei, M. Wiesener, K. Eckardt (2004)
Differentiating the functional role of hypoxia‐inducible factor (HIF)‐1α and HIF‐2α (EPAS‐1) by the use of RNA interference: erythropoietin is a HIF‐2α target gene in Hep3B and Kelly cellsThe FASEB Journal, 18
P. Carmeliet, Y. Dor, J. Herbert, D. Fukumura, K. Brusselmans, M. Dewerchin, M. Neeman, F. Bono, R. Abramovitch, P. Maxwell, C. Koch, P. Ratcliffe, L. Moons, R. Jain, D. Collen, E. Keshet (1998)
Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesisNature, 394
A. Kung, Stream Wang, J. Klco, W. Kaelin, D. Livingston (2000)
Suppression of tumor growth through disruption of hypoxia-inducible transcriptionNature Medicine, 6
Natalie Paulsen, Alexander Brychzy, Marie Fournier, R. Klausner, J. Gnarra, Arnim Pause, Arnim Pause, Stephen Lee (2001)
Role of transforming growth factor-alpha in von Hippel--Lindau (VHL)(-/-) clear cell renal carcinoma cell proliferation: a possible mechanism coupling VHL tumor suppressor inactivation and tumorigenesis.Proceedings of the National Academy of Sciences of the United States of America, 98 4
M. Krieg, R. Haas, H. Brauch, T. Acker, I. Flamme, K. Plate (2000)
Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function.Oncogene, 19 48
S. Kothari, J. Cizeau, E. McMillan-Ward, S. Israels, M. Bailes, K. Ens, L. Kirshenbaum, S. Gibson (2003)
BNIP3 plays a role in hypoxic cell death in human epithelial cells that is inhibited by growth factors EGF and IGFOncogene, 22
A. Kung, S. Zabludoff, D. France, S. Freedman, E. Tanner, Annelisa Vieira, S. Cornell-Kennon, Jennifer Lee, B. Wang, Jamin Wang, K. Memmert, H. Naegeli, F. Petersen, M. Eck, K. Bair, A. Wood, D. Livingston (2004)
Small molecule blockade of transcriptional coactivation of the hypoxia-inducible factor pathway.Cancer cell, 6 1
MOL. CELL. BIOL
A. Harris (2002)
Hypoxia — a key regulatory factor in tumour growthNature Reviews Cancer, 2
Canwen Jiang, Hsienwie Lu, K. Vincent, S. Shankara, A. Belanger, Seng Cheng, G. Akita, R. Kelly, M. Goldberg, R. Gregory (2002)
Gene expression profiles in human cardiac cells subjected to hypoxia or expressing a hybrid form of HIF-1αPhysiological Genomics, 8
C. Wykoff, C. Sotiriou, M. Cockman, P. Ratcliffe, P. Maxwell, E. Liu, A. Harris (2004)
Gene array of VHL mutation and hypoxia shows novel hypoxia-induced genes and that cyclin D1 is a VHL target geneBritish Journal of Cancer, 90
J. O'rourke, Ya-min Tian, P. Ratcliffe, C. Pugh (1999)
Oxygen-regulated and Transactivating Domains in Endothelial PAS Protein 1: Comparison with Hypoxia-inducible Factor-1α*The Journal of Biological Chemistry, 274
M. Zatyka, N. Silva, S. Clifford, M. Morris, M. Wiesener, K. Eckardt, R. Houlston, F. Richards, F. Latif, E. Maher (2002)
Identification of cyclin D1 and other novel targets for the von Hippel-Lindau tumor suppressor gene by expression array analysis and investigation of cyclin D1 genotype as a modifier in von Hippel-Lindau disease.Cancer research, 62 13
J. Jacobs, K. Kieboom, S. Marino, R. DePinho, M. Lohuizen (1999)
The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locusNature, 397
H. Sowter, R. Raval, John Moore, P. Ratcliffe, A. Harris (2003)
Predominant role of hypoxia-inducible transcription factor (Hif)-1alpha versus Hif-2alpha in regulation of the transcriptional response to hypoxia.Cancer research, 63 19
K. Kondo, J. Klco, E. Nakamura, M. Lechpammer, W. Kaelin (2002)
Inhibition of HIF is necessary for tumor suppression by the von Hippel-Lindau protein.Cancer cell, 1 3
Sang-ki Park, A. Dadak, V. Haase, Lucrezia Fontana, A. Giaccia, R. Johnson (2003)
Hypoxia-Induced Gene Expression Occurs Solely through the Action of Hypoxia-Inducible Factor 1α (HIF-1α): Role of Cytoplasmic Trapping of HIF-2αMolecular and Cellular Biology, 23
C. Velde, J. Cizeau, D. Dubik, J. Alimonti, T. Brown, S. Israels, R. Hakem, A. Greenberg (2000)
BNIP3 and Genetic Control of Necrosis-Like Cell Death through the Mitochondrial Permeability Transition PoreMolecular and Cellular Biology, 20
H. Ryan, J. Lo, R. Johnson (1998)
HIF‐1α is required for solid tumor formation and embryonic vascularizationThe EMBO Journal, 17
S. Mandriota, K. Turner, D. Davies, P. Murray, N. Morgan, H. Sowter, C. Wykoff, E. Maher, A. Harris, P. Ratcliffe, P. Maxwell (2002)
HIF activation identifies early lesions in VHL kidneys: evidence for site-specific tumor suppressor function in the nephron.Cancer cell, 1 5
T. Seagroves, H. Ryan, Han Lu, B. Wouters, M. Knapp, P. Thibault, K. Laderoute, R. Johnson (2001)
Transcription Factor HIF-1 Is a Necessary Mediator of the Pasteur Effect in Mammalian CellsMolecular and Cellular Biology, 21
P. Maxwell, M. Wiesener, G. Chang, S. Clifford, E. Vaux, M. Cockman, C. Wykoff, C. Pugh, E. Maher, P. Ratcliffe (1999)
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysisNature, 399
N. Iyer, L. Kotch, F. Agani, S. Leung, E. Laughner, R. Wenger, M. Gassmann, J. Gearhart, A. Lawler, A. Yu, G. Semenza (1998)
Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 alpha.Genes & development, 12 2
M. Bui, D. Seligson, Ken‐ryu Han, A. Pantuck, F. Dorey, Yunda Huang, S. Horvath, B. Leibovich, S. Chopra, S. Liao, E. Stanbridge, M. Lerman, A. Palotie, R. Figlin, A. Belldegrun (2003)
Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: implications for prognosis and therapy.Clinical cancer research : an official journal of the American Association for Cancer Research, 9 2
J. Závada, Z. Zavadova, S. Pastoreková, F. Čiampor, J. Pastorek, V. Zelník (1993)
Expression of MaTu‐MN protein in human tumor cultures and in clinical specimensInternational Journal of Cancer, 54
M. Wiesener, H. Turley, W. Allen, C. Willam, K. Eckardt, K. Talks, S. Wood, K. Gatter, A. Harris, C. Pugh, P. Ratcliffe, P. Maxwell (1998)
Induction of endothelial PAS domain protein-1 by hypoxia: characterization and comparison with hypoxia-inducible factor-1alpha.Blood, 92 7
R. Ravi, B. Mookerjee, Z. Bhujwalla, C. Sutter, D. Artemov, Qinwen Zeng, L. Dillehay, A. Madan, G. Semenza, A. Bedi (2000)
Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1alpha.Genes & development, 14 1
H. Tian, S. McKnight, D. Russell (1997)
Endothelial PAS domain protein 1 (EPAS1), a transcription factor selectively expressed in endothelial cells.Genes & development, 11 1
R. Bindra, J. Vasselli, R. Stearman, W. Linehan, R. Klausner (2002)
VHL-mediated hypoxia regulation of cyclin D1 in renal carcinoma cells.Cancer research, 62 11
G. Semenza (2003)
Targeting HIF-1 for cancer therapyNature Reviews Cancer, 3
M. Krieg, R. Haas, H. Brauch, T. Acker, I. Flamme, K. Plate (2000)
Up-regulation of hypoxia-inducible factors HIF-1α and HIF-2α under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of functionOncogene, 19
R. Bruick (2000)
Expression of the gene encoding the proapoptotic Nip3 protein is induced by hypoxia.Proceedings of the National Academy of Sciences of the United States of America, 97 16
H. Ryan, J. Lo, R. Johnson (1998)
HIF-1 alpha is required for solid tumor formation and embryonic vascularization.The EMBO journal, 17 11
T. Ebert, N. Bander, C. Finstad, R. Ramsawak, Lloyd Old (1990)
Establishment and characterization of human renal cancer and normal kidney cell lines.Cancer research, 50 17
Shu-Yuan Liao, O. Aurelio, Kevin Jan, Jan Zavada, Eric Stanbridge (1997)
Identification of the MN/CA9 protein as a reliable diagnostic biomarker of clear cell carcinoma of the kidney.Cancer research, 57 14
A. Rapisarda, B. Uranchimeg, D. Scudiero, M. Selby, E. Sausville, R. Shoemaker, G. Melillo (2002)
Identification of small molecule inhibitors of hypoxia-inducible factor 1 transcriptional activation pathway.Cancer research, 62 15
W. Kaelin (2003)
The von Hippel-Lindau gene, kidney cancer, and oxygen sensing.Journal of the American Society of Nephrology : JASN, 14 11
Jung-Hyun Min, Haifeng Yang, M. Ivan, F. Gertler, W. Kaelin, N. Pavletich (2002)
Structure of an HIF-1α-pVHL Complex: Hydroxyproline Recognition in SignalingScience, 296
O. Iliopoulos, A. Kibel, S. Gray, W. Kaelin (1995)
Tumour suppression by the human von Hippel-Lindau gene productNature Medicine, 1
M. Koshiji, Y. Kageyama, Erin Pete, I. Horikawa, J. Barrett, L. Huang (2004)
HIF‐1α induces cell cycle arrest by functionally counteracting MycThe EMBO Journal, 23
W. Hon, Michael Wilson, K. Harlos, T. Claridge, C. Schofield, C. Pugh, P. Maxwell, P. Ratcliffe, D. Stuart, E. Jones (2002)
Structural basis for the recognition of hydroxyproline in HIF-1α by pVHLNature, 417
W. Kaelin (2002)
Molecular basis of the VHL hereditary cancer syndromeNature Reviews Cancer, 2
C. Sherr (1996)
Cancer Cell CyclesScience, 274
Keiji Tanimoto, Y. Makino, T. Pereira, L. Poellinger (2000)
Mechanism of regulation of the hypoxia‐inducible factor‐1α by the von Hippel‐Lindau tumor suppressor proteinThe EMBO Journal, 19
(2005)
HIF-1␣ AND HIF-2␣ IN RCC
P. Maxwell, G. Dachs, J. Gleadle, L. Nicholls, A. Harris, I. Stratford, O. Hankinson, C. Pugh, P. Ratcliffe (1997)
Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth.Proceedings of the National Academy of Sciences of the United States of America, 94 15
M. Höckel, P. Vaupel (2001)
Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects.Journal of the National Cancer Institute, 93 4
J. Maranchie, J. Vasselli, J. Riss, J. Bonifacino, W. Linehan, R. Klausner (2002)
The contribution of VHL substrate binding and HIF1-alpha to the phenotype of VHL loss in renal cell carcinoma.Cancer cell, 1 3
M. Zimmer, D. Doucette, N. Siddiqui, O. Iliopoulos (2004)
Inhibition of hypoxia-inducible factor is sufficient for growth suppression of VHL-/- tumors.Molecular cancer research : MCR, 2 2
Molecular and Cellular Biology – Unpaywall
Published: Jun 17, 2005
Access the full text.
Sign up today, get DeepDyve free for 14 days.